BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7328563)

  • 1. Phagocytosis and degradation of DNA-antiDNA complexes by human phagocytes. Influence of rheumatoid factors.
    Lamers MC; de Groot ER; Roos D
    J Rheumatol; 1981; 8(6):880-8. PubMed ID: 7328563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phagocytosis and degradation of DNA-anti-DNA complexes by human phagocytes: influence of the antibody class.
    Lamers MC; de Groot ER; Roos D
    Lab Invest; 1982 Apr; 46(4):393-9. PubMed ID: 7070053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phagocytosis and degradation of DNA-anti-DNA complexes by human phagocytes II. Influence of the size of the complexes.
    Lamers MC; De Groot ER; Roos D
    Eur J Immunol; 1981 Oct; 11(10):764-8. PubMed ID: 7308286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of the complement activation capacity of soluble IgG aggregates and immune complexes by IgM-rheumatoid factor.
    Doekes G; Schouten J; Cats A; Daha MR
    Immunology; 1985 Jul; 55(3):555-64. PubMed ID: 4018839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The roles of IgG, IgM rheumatoid factor, and their complexes in the induction of polymorphonuclear leukocyte chemotactic factor from complement.
    Wagner T; Abraham G; Baum J
    J Clin Invest; 1974 Jun; 53(6):1503-11. PubMed ID: 4133792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phagocytosis and degradation of DNA-anti-DNA complexes by human phagocytes. I. Assay conditions, quantitative aspects and differences between human blood monocytes and neutrophils.
    Lamers MC; De Groot ER; Roos D
    Eur J Immunol; 1981 Oct; 11(10):757-64. PubMed ID: 7308285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interference of rheumatoid factor activity by aspartame, a dipeptide methyl ester.
    Ramsland PA; Movafagh BF; Reichlin M; Edmundson AB
    J Mol Recognit; 1999; 12(5):249-57. PubMed ID: 10777254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interference of rheumatoid factor activity by aspartame, a dipeptide methyl ester.
    Ramsland PA; Movafagh BF; Reichlin M; Edmundson AB
    J Mol Recognit; 1999; 12(4):249-57. PubMed ID: 10440996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rheumatoid factors in the pathogenesis of rheumatoid arthritis.
    Mannik M
    J Rheumatol Suppl; 1992 Jan; 32():46-9. PubMed ID: 1613732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of rheumatoid factor on complement-mediated phagocytosis.
    McDuffie FC; Brumfield HW
    J Clin Invest; 1972 Dec; 51(12):3007-14. PubMed ID: 4640945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of rheumatoid factors and normal human sera on immune complex-Fc gamma R interaction.
    Isturiz MA; Giordano M; Serebrinsky GP
    Clin Exp Immunol; 1983 Oct; 54(1):225-31. PubMed ID: 6225582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of circulating antigen-antibody complexes by their inhibitory effect on the agglutination of IgG-coated particles by rheumatioid factor of Clq.
    Lurhuma AZ; Cambiaso CL; Masson PL; Heremans JF
    Clin Exp Immunol; 1976 Aug; 25(2):212-26. PubMed ID: 954232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The binding constants of IgM rheumatoid factors and their univalent fragments for native and aggregated human IgG;
    Dissanayake S; Hay FC; Roitt IM
    Immunology; 1977 Mar; 32(3):309-18. PubMed ID: 849879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of IgM rheumatoid factor in experimental immune vasculitis.
    Floyd M; Tesar JT
    Clin Exp Immunol; 1979 Apr; 36(1):165-74. PubMed ID: 157238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetic measurement of the interaction of rheumatoid factor with IgG-coated latex particles and the influence of the first component of human complement.
    Hällgren R
    Clin Exp Immunol; 1980 Jan; 39(1):154-63. PubMed ID: 6771071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissociation of soluble antigen-antibody complexes by rheumatoid factor IgM.
    Alkner U
    Scand J Immunol; 1983 Aug; 18(2):131-6. PubMed ID: 6224291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lysosomal enzyme release from polymorphonuclear leukocytes induced by immune complexes of IgM and of IgG.
    Lucisano YM; Mantovani B
    J Immunol; 1984 Apr; 132(4):2015-20. PubMed ID: 6699405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cryoglobulinemia type II].
    Madi N; Schifferli JA
    Nephrologie; 1990; 11(4):237-41. PubMed ID: 2074925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 7S IgG rheumatoid factor and hidden 19S IgM rheumatoid factor in juvenile chronic arthritis.
    Roizenblatt S; Goldenberg J; Gabriel A; Hilário MO; Atra E
    Allergol Immunopathol (Madr); 1993; 21(5):197-200. PubMed ID: 8160565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoreactants in murine lupus nephritis: effects of azathioprine.
    Cavallo T; Granholm NA; Graves K
    J Clin Lab Immunol; 1984 Mar; 13(3):117-21. PubMed ID: 6609237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.